Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
Archive print banner
National Healthcare Disparities Report, 2007

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to www.ahrq.gov for current information.

Table 176
Percent of patients with adverse drug events: anticoagulant-related IV heparin, United States, 2005a
Population group Percent SE
Total   13.0 0.7
Age Under 65 14.0 1.9
65-74 11.7 1.1
75-84 13.5 1.2
85 and over 14.3 2.2
Gender Female 14.5 1.1
Male 11.6 0.9
Race White 13.0 0.8
Black 10.7 2.0
Other 17.5 3.7
Diabetes Yes 13.6 1.2
No 12.6 0.9
Obesity Yes 12.2 1.8
No 13.1 0.8
Cerebrovascular disease Yes 14.6 1.4
No 12.4 0.8
CHF/pulmonary edema Yes 17.0 1.3
No 10.5 0.8
COPD Yes 13.9 1.3
No 12.6 0.8
Smoking Yes 15.1 1.8
No 12.6 0.8
Corticosteroids Yes 12.7 0.7
No 16.8 3.1
Coronary artery disease Yes 14.4 0.9
No 9.5 1.1
Renal disease Yes 16.2 1.3
No 11.1 0.8

a Data include Medicare beneficiaries discharged from January to December.

Key: CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease; SE: standard error.

Source: Centers for Medicare & Medicaid Services, Medicare Patient Safety Monitoring System.

 

The information on this page is archived and provided for reference purposes only.

 

AHRQ Advancing Excellence in Health Care